GlassScriptPhysician profile
Dana Dudley
NPI 1205410230
$17,736.15
in general payments reported to CMS, 2019-2025
70 companies · $5,214 in 2025
The $5,214 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $319 · 2022: $3,111 · 2023: $3,874 · 2024: $5,219 · 2025: $5,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Long Term Medical Supply Or Device Loan: $2,113 · Education: $83.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,110.39 |
| Long Term Medical Supply Or Device Loan | $2,113.03 |
| Education | $83.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,393.65 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,194.04 | 2022-2025 | Calquence, Lynparza, Tagrisso |
| Merck Sharp & Dohme LLC | $1,126.53 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $875.37 | 2022-2025 | Erleada, Darzalex, Balversa |
| Daiichi Sankyo INC. | $841.92 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Pfizer INC. | $808.89 | 2022-2025 | |
| Seagen INC. | $765.08 | 2021-2023 | Tukysa, Adcetris, Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $459.30 | 2022-2025 | |
| Amgen INC. | $445.44 | 2021-2024 | Kyprolis, Blincyto, Lumakras |
| Celgene Corporation | $398.68 | 2022-2025 | Reblozyl, Pomalyst, Opdivo |
| E.R. Squibb & Sons, L.L.C. | $394.80 | 2022-2025 | Opdivo, Opdualag |
| Lilly USA, LLC | $342.29 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Genentech USA, INC. | $302.20 | 2022-2025 | Tecentriq, Alecensa, Rozlytrek |
| Exelixis INC. | $299.57 | 2021-2025 | Cabometyx |
| Eisai INC. | $265.22 | 2021-2025 |
Show all 70 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $254.36 | 2022-2025 | Libtayo |
| Taiho Oncology, INC. | $246.20 | 2023-2025 | |
| Incyte Corporation | $243.60 | 2022-2025 | Jakafi, Monjuvi, Pemazyre |
| Abbvie INC. | $228.90 | 2022-2025 | |
| Coherus Oncology, INC. | $215.68 | 2021-2025 | Udenyca |
| Sobi, INC | $210.88 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $207.20 | 2022-2025 | Onivyde, Somatuline Depot |
| Astellas Pharma US INC | $206.24 | 2022-2025 | Vyloy, Xtandi |
| Glaxosmithkline, LLC. | $201.55 | 2021-2025 | Ojjaara, Zejula, Jemperli |
| Puma Biotechnology, INC. | $197.05 | 2022-2025 | |
| Stemline Therapeutics INC. | $196.37 | 2022-2025 | Orserdu, Elzonris |
| Rigel Pharmaceuticals, INC. | $187.98 | 2022-2024 | Rezlidhia, Tavalisse |
| Array Biopharma INC | $177.43 | 2024-2025 | Braftovi, Mektovi, Tukysa |
| Beigene USA, INC. | $172.59 | 2023-2025 | Brukinsa, Tevimbra |
| Alexion Pharmaceuticals, INC. | $165.52 | 2022-2025 | Ultomiris |
| Acrotech Biopharma INC. | $149.28 | 2022-2024 | Beleodaq |
| Pharmacyclics LLC, An Abbvie Company | $138.09 | 2022-2023 | Imbruvica, Epkinly |
| Takeda Pharmaceuticals U.S.A., INC. | $132.86 | 2022-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Jazz Pharmaceuticals INC. | $126.36 | 2023-2025 | |
| Aveo Pharmaceuticals, INC. | $126.24 | 2022-2025 | Fotivda |
| Pharmaessentia USA Corporation | $123.65 | 2024-2025 | Besremi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.15 | 2023-2025 | Gilotrif |
| Karyopharm Therapeutics INC. | $123.00 | 2021-2024 | Xpovio |
| Genzyme Corporation | $118.76 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $116.80 | 2024-2025 | Provenge |
| Gilead Sciences, INC. | $111.44 | 2023-2025 | Trodelvy |
| Sanofi-Aventis U.S. LLC | $99.95 | 2022 | |
| Pharmacosmos Therapeutics INC. | $97.09 | 2024-2025 | Cosela, Monoferric |
| Tersera Therapeutics LLC | $86.32 | 2025 | Quzyttir, Zoladex |
| Geron Corporation | $84.58 | 2025 | Rytelo |
| Beone Medicines USA, INC. | $81.63 | 2025 | Brukinsa, Tevimbra |
| Adc Therapeutics America, INC. | $77.70 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $76.19 | 2023-2025 | Orgovyx |
| Genmab U.S., INC. | $60.79 | 2023-2025 | Epkinly |
| Amneal Pharmaceuticals LLC | $57.56 | 2024-2025 | Alymsys, Avastin |
| Servier Pharmaceuticals LLC | $53.19 | 2022-2024 | |
| Azurity Pharmaceuticals, INC. | $52.39 | 2025 | Danziten |
| Emd Serono, INC. | $49.93 | 2025 | |
| Kite Pharma, INC. | $49.49 | 2023-2025 | Yescarta |
| Deciphera Pharmaceuticals INC. | $44.85 | 2024-2025 | Qinlock, Tgct |
| Morphosys, US INC. | $43.42 | 2022-2023 | Monjuvi |
| Kyowa Kirin, INC. | $33.56 | 2023-2025 | Poteligeo |
| Tempus Ai, INC | $27.98 | 2025 | Xt Cdx |
| Novocure INC. | $27.20 | 2024 | Optune |
| Fennec Pharmaceuticals, INC. | $22.78 | 2025 | Fyarro |
| Mirati Therapeutics, INC. | $22.45 | 2023 | Krazati |
| Avyxa Pharma, LLC | $22.14 | 2025 | |
| Iovance Biotherapeutics, INC. | $21.54 | 2025 | Amtagvi |
| Inari Medical, INC. | $21.13 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Foundation Medicine, INC. | $20.51 | 2023 | |
| Cti Biopharma Corp. | $20.12 | 2023 | Vonjo |
| G1 Therapeutics, INC. | $18.75 | 2023 | Cosela |
| Agios Pharmaceuticals, INC. | $18.14 | 2023 | Pyrukynd |
| Accord Healthcare, INC. | $17.56 | 2023 | |
| Spectrum Pharmaceuticals INC. | $13.05 | 2023 | Rolvedon |
Drugs and devices associated with these payments
Kisqali $2,323Keytruda $964Enhertu $478Lynparza $437Nubeqa $379Xofigo $324Tukysa $322Jaypirca $298Verzenio $298Calquence $296Fabhalta $293Scemblix $285Erleada $280Ibrance $260Inqovi $246Lonsurf $246Imbruvica $244Opdivo $233Darzalex $226Lenvima $222Brukinsa $220Adcetris $214Tecentriq $209Onivyde $191Avastin $186Orgovyx $184Rozlytrek $163Alecensa $163Libtayo $161Injectafer $160Braftovi $160Reblozyl $159Elrexfio $156Jakafi $154Padcev $153Orserdu $152Ultomiris $151Xtandi $147Mektovi $145Datroway $144Epkinly $142Beleodaq $136Cabometyx $134Somatuline Depot $132Welireg $127Zepzelca $126Besremi $124Rezlidhia $122Tavalisse $122Provenge $117Ojjaara $117Tagrisso $115Promacta $109Fotivda $109Talzenna $107Opdualag $100Pomalyst $97.87Inlyta $90.91Gilotrif $90.84Monjuvi $90.84Gavreto $90.62Rytelo $84.58Xpovio $78.11Retevmo $73.71Piqray $71.57Cosela $71.50Trodelvy $70.97Lorbrena $70.52Balversa $68.43Tasigna $67.25Rybrevant $66.79Bosulif $66.32Quzyttir $66.32Venclexta $65.49Sarclisa $64.40Doptelet $62.97Zynlonta $62.39Paxlovid $56.35Comirnaty $56.35Kyprolis $52.56Danziten $52.39Tecvayli $50.41Mekinist $45.83Blincyto $45.51Qinlock $44.85Monoferric $44.34Nerlynx $43.94Akeega $43.54Vonjo $38.57Vyloy $37.74Pemazyre $36.11Ninlaro $36.06Wayrilz $35.16Tevimbra $34.29Alymsys $33.92Poteligeo $33.56Udenyca $31.75Lumakras $31.69Fruzaqla $29.76Xt Cdx $27.98
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Dudley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.